<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Procainamide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Procainamide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Procainamide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Procainamide</b> is a medication of the antiarrhythmic class used for the treatment of cardiac arrhythmias. It is classified by the Vaughan Williams classification system as class Ia; thus it is a sodium channel blocker of cardiomyocytes. In addition to blocking the <i>I</i><sub>Na</sub> current, it inhibits the <i>I</i><sub>Kr</sub> rectifier K+ current.<span class="mw-ref" id="cite_ref-Osadchii_1-0"><a href="#cite_note-Osadchii-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Procainamide is also known to induce a voltage-dependent open channel block on the batrachotoxin (BTX)-activated sodium channels in cardiomyocytes.<span class="mw-ref" id="cite_ref-Zamponi_2-0"><a href="#cite_note-Zamponi-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Procainamide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Procainamide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Procainamide.svg.png" data-file-width="139" data-file-height="59" data-file-type="drawing" height="93" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>p</span><span>r</span><span>oʊ</span><span>ˈ</span><span>k</span><span>eɪ</span><span>n</span><span>əm</span><span>aɪ</span><span>d</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Pronestyl, Procan, Procanbid, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/procainamide-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/procainamide-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/procainamide-hydrochloride.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>IV, IM, by mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>C01BA02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C01BA02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C01BA02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C01BA02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>85% (by mouth)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>15 to 20%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (CYP2D6-mediated)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>~2.5 to 4.5 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">4-amino-<i>N</i>-(2-diethylaminoethyl) benzamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=51-06-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=51-06-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=51-06-9" class="external text external">51-06-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/4913  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/4913'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/4913" class="external text external">4913</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4811  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4811'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4811" class="external text external">4811</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01035'" tppabs="https://www.drugbank.ca/drugs/DB01035" class="external text external">DB01035</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4744.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4744.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4744.html" class="external text external">4744</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=L39WTC366D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=L39WTC366D'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=L39WTC366D" class="external text external">L39WTC366D</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D08421  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D08421'" tppabs="https://www.kegg.jp/entry/D08421" class="external text external">D08421</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8428'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8428" class="external text external">CHEBI:8428</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL640  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL640'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL640" class="external text external">ChEMBL640</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7023512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7023512'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7023512" class="external text external">DTXSID7023512</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.000.072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.000.072'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.072" class="external text external">100.000.072</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>13</sub><span>H</span><sub>21</sub><span>N</span><sub>3</sub><span>O</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">235.331</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1ccc%28N%29cc1%29NCCN%28CC%29CC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1ccc%28N%29cc1%29NCCN%28CC%29CC'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1ccc%28N%29cc1%29NCCN%28CC%29CC" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(c1ccc(N)cc1)NCCN(CC)CC</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:REQCZEXYDRLIBE-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477172111&page2=Procainamide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477172111&page2=Procainamide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477172111&page2=Procainamide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Uses">Uses</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Medical">Medical</h3></summary>
    
<p>Procainamide is used for treating ventricular arrhythmias: ventricular ectopy and tachycardia and supraventricular arrhythmias: atrial fibrillation, and re-entrant and automatic supraventricular tachycardia.<span class="mw-ref" id="cite_ref-Gould_3-0"><a href="#cite_note-Gould-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> For example, it can be used to convert new-onset atrial fibrillation, though it is suboptimal for this purpose.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>It is administered by mouth, by intramuscular injection, or intravenously.<span class="mw-ref" id="cite_ref-ten_5-0"><a href="#cite_note-ten-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Others">Others</h3></summary>
    
<p>It has been also been used as a chromatography resin because it somewhat binds protein.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>There are many side effects following the induction of procainamide. These adverse effects are ventricular dysrhythmia, bradycardia, hypotension and shock. The adverse effects occur even more often if the daily doses are increased. Procainamide may also lead to drug fever and other allergic responses. There is also a chance that drug-induced lupus erythematosus occurs, which at the same time leads to arthralgia, myalgia and pleurisy. Most of these side effects may occur due to the acetylation of procainamide.<span class="mw-ref" id="cite_ref-adverse_11-0"><a href="#cite_note-adverse-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Toxicity">Toxicity</h3></summary>
    
<p>There is a close line between the plasma concentrations of the therapeutic and toxic effect, therefore a high risk for toxicity.<span class="mw-ref" id="cite_ref-adverse_11-1"><a href="#cite_note-adverse-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Many symptoms resemble systemic lupus erythematosus because procainamide reactivates <a href="Hydroxylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxylamine" title="Hydroxylamine">hydroxylamine</a> and nitroso metabolites, which bind to histone proteins and are toxic to lymphocytes. The hydroxylamine and nitroso metabolites are also toxic to bone marrow cells and can cause agranulocytosis. These metabolites are formed due to the activation of polymorphonuclear leukocytes. These leukocytes release myeloperoxidase and <a href="Hydrogen_peroxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrogen_peroxide" title="Hydrogen peroxide">hydrogen peroxide</a>, which oxidize the primary aromatic amine of procainamide to form procainamide hydroxylamine. The release of hydrogen peroxide is also called a respiratory burst, which occurs for procainamide in monocytes but not in lymphocytes. Furthermore, the metabolites can be formed by activated neutrophils. These metabolites could then bind to their cell membranes and cause a release of autoantibodies which would react with the neutrophils.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Procainamide hydroxylamine has more cytotoxicity by hindering the response of lymphocytes to T-cell and B-cell mitogens. Hydroxylamine can also generate methemoglobin, a protein that could hinder further oxygen exchange.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>It was also detected that the antiarrhythmic drug procainamide interferes with pacemakers. A toxic level of procainamide leads to decrease in ventricular conduction velocity and increase of the ventricular refractory period. This results in a disturbance in the artificial membrane potential and leads to a supraventricular tachycardia which induces failure of the pacemaker and death.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Thus, it prolongs QT interval of action potential and increases the risk of torsade de pointes.<span class="mw-ref" id="cite_ref-Osadchii_1-1"><a href="#cite_note-Osadchii-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>Procainamide could initiate leukopenia and/or agranulocytosis, which are serious hematologic disorders, and is also known for causing gastrointestinal disturbances and aggravating pre-existing abnormalities in impulse initiation and propagation.<span class="mw-ref" id="cite_ref-Gould_3-1"><a href="#cite_note-Gould-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>Procainamide works as an anti-arrhythmic agent and is used to treat cardiac arrhythmia. It induces rapid block of the batrachotoxin (BTX)-activated sodium channels of the heart muscle and acts as antagonist to long-gating closures. The block is voltage-dependent and can occur from both sides; either from the intracellular or the extracellular side. Blocking from the extracellular side is weaker than from the intracellular side because it occurs via the <span class="new">hydrophobic pathway</span>. Procainamide is present in charged form and probably requires a direct hydrophobic access to the binding site for blocking of the channel. Furthermore, blocking of the channel shows a decreased voltage sensitivity, which may result from the loss of voltage dependence of the blocking rate. Due to its charged and hydrophilic form, procainamide has its effect from the internal side, where it causes blockage of voltage-dependent, open channels. With increasing concentration of procainamide, the frequency of long blockage becomes less without the duration of blockage being affected. The rate of fast blocking is determined by the membrane depolarization. Membrane depolarization leads to increased blocking and decreased unblocking of the channels. Procainamide slows the conduction velocity and increases the refractory period, such that the maximal rate of depolarization is reduced.<span class="mw-ref" id="cite_ref-Zamponi_2-1"><a href="#cite_note-Zamponi-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Metabolism">Metabolism</h3></summary>
    
<p>Procainamide is metabolized via different pathways. The most common one is the acetylation of procainamide to the less-toxic N-acetylprocainamide.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The rate of acetylation is genetically determined. There are two phenotypes that result from the acetylation process, namely the slow and rapid acetylator. Procainamide can also be oxidized by the cytochrome P-450 to a reactive oxide metabolite. But it seems that acetylation of the nitrogen group of procainamide decrease the amount of the chemical that would be available for the oxidative route.<span class="mw-ref" id="cite_ref-Uetrecht,_J._P._1981_16-0"><a href="#cite_note-Uetrecht,_J._P._1981-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Other metabolites of procainamide include desethyl-N-acetylprocainamide, desethylprocainamide, p-aminobenzoic acid, which are excreted via the urine.  N-acetyl-4-aminobenzoic acid as well as N-acetyl-3-hydroxyprocainamide, N-acetylprocainamide-N-oxide and N-acetyl-4-aminohippuric acid are also metabolites of procainamide.<span class="mw-ref" id="cite_ref-Uetrecht,_J._P._1981_16-1"><a href="#cite_note-Uetrecht,_J._P._1981-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>4-amino-N-2-(diethylamino)ethyl-benzamide (also known as <a href="Diethylethanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylethanolamine" title="Diethylethanolamine">para-amino-N-2-(diethylamino)ethyl-benzamide</a> because the amino substituent is attached to the para-position, Arene substitution patterns of the benzene ring) is a synthetic organic compound with the chemical formula  C13-H21-N3-O.<span class="mw-ref" id="cite_ref-Drug_17-0"><a href="#cite_note-Drug-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>Procainamide is structurally similar to <a href="Procaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procaine" title="Procaine">procaine</a>, but in place of an ester group, procainamide contains an amide group. This substitution is the reason why procainamide exhibits a longer half-life time than procaine.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Procainamide belongs to the <a href="Benzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamides" title="Benzamides" class="mw-redirect">aminobenzamides</a>. These are aromatic carboxylic acid derivatives consisting of an amide with a <a href="Benzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamide" title="Benzamide">benzamide</a> moiety and a <a href="Triethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triethylamine" title="Triethylamine">triethylamine</a> attached to the amide <a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">nitrogen</a>.<span class="mw-ref" id="cite_ref-Drug_17-1"><a href="#cite_note-Drug-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>In certain lines, the <i>para</i>-amino group might become a target site to attach further paraphernalia, e.g. <i>ref.</i> Ex18 in <span><a href="javascript:if(confirm('https://www.google.com/patents/US7115750  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US7115750'" tppabs="https://www.google.com/patents/US7115750" class="external text external">U.S. Patent 7,115,750</a></span>.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Procainamide was approved by the US FDA on June 2, 1950, under the brand name "Pronestyl".<span class="mw-ref" id="cite_ref-dafda_22-0"><a href="#cite_note-dafda-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> It was launched by Bristol-Myers Squibb in 1951.<span class="mw-ref" id="cite_ref-pmid18610401_23-0"><a href="#cite_note-pmid18610401-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span>
Due to the loss of Indonesia in World War II, the source for cinchona alkaloids, a precursor of <a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">quinidine</a>, was reduced. This led to research for a new antiarrhythmic drug. As a result, <a href="Procaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procaine" title="Procaine">procaine</a> was discovered, which has similar cardiac effects as quinidine.<span class="mw-ref" id="cite_ref-one_24-0"><a href="#cite_note-one-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> In 1936 it was found by Mautz that by applying it directly on the myocardium, the ventricular threshold for electrical stimulation was elevated.<span class="mw-ref" id="cite_ref-pmid18610401_23-1"><a href="#cite_note-pmid18610401-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> This mechanism is responsible for the antiarrhythmic effect. However, due to the short duration of action, caused by rapid enzymatic hydrolysis, its therapeutic applications were limited.<span class="mw-ref" id="cite_ref-three_25-0"><a href="#cite_note-three-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> In addition, procaine also caused tremors and respiratory depression.<span class="mw-ref" id="cite_ref-three_25-1"><a href="#cite_note-three-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-two_26-0"><a href="#cite_note-two-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> All these adverse features stimulated the search for an alternative to procaine. Studies were done on various congeners and metabolites and this ultimately led to the discovery of procainamide by Mark <i>et al</i>. It was found that procainamide was effective for treating ventricular arrhythmias, but it had the same toxicity profile as quinidine, and it could cause systemic lupus erythematosus-like syndrome.<span class="mw-ref" id="cite_ref-one_24-1"><a href="#cite_note-one-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-two_26-1"><a href="#cite_note-two-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> These negative characteristics slowed the search for new antiarrhythmics based on the chemical structure of procainamide. In 1970 only five drugs were reported. These were the cardiac glycosides, <a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">quinidine</a>, <a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">propranolol</a>, <a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">lidocaine</a> and diphenylhydantoin. In January 1996, extended release procainamide hydrochloride (Procanbid extended-release tablets) was approved by the FDA.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Osadchii-1"> <span id="mw-reference-text-cite_note-Osadchii-1" class="mw-reference-text"><cite id="CITEREFOsadchii2014" class="citation journal cs1">Osadchii OE (August 2014). "Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig". <i>Fundamental &amp; Clinical Pharmacology</i>. <b>28</b> (4): 382–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Ffcp.12046  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Ffcp.12046'" tppabs="https://doi.org/10.1111%2Ffcp.12046" class="external text external">10.1111/fcp.12046</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23952942  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23952942'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23952942" class="external text external">23952942</a>.</cite></span></li><li id="cite_note-Zamponi-2"> <span id="mw-reference-text-cite_note-Zamponi-2" class="mw-reference-text"><cite id="CITEREFZamponiSuiCoddingFrench1993" class="citation journal cs1">Zamponi GW, Sui X, Codding PW, French RJ (December 1993). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1225974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1225974'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1225974" class="external text external">"Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation"</a>. <i>Biophysical Journal</i>. <b>65</b> (6): 2324–34. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1993BpJ....65.2324Z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1993BpJ....65.2324Z'" tppabs="https://ui.adsabs.harvard.edu/abs/1993BpJ....65.2324Z" class="external text external">1993BpJ....65.2324Z</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0006-3495%2893%2981291-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0006-3495%2893%2981291-8'" tppabs="https://doi.org/10.1016%2FS0006-3495%2893%2981291-8" class="external text external">10.1016/S0006-3495(93)81291-8</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1225974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1225974'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1225974" class="external text external">1225974</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8312472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8312472'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8312472" class="external text external">8312472</a>.</cite></span></li><li id="cite_note-Gould-3"> <span id="mw-reference-text-cite_note-Gould-3" class="mw-reference-text"><cite id="CITEREFGould1983" class="citation book cs1">Gould LA, ed. (1983). <i>Drug Treatment of Cardiac Arrhythmias</i>. Mount Kisco: Futura Publishing Company. pp.<span>&nbsp;</span>73–74. ISBN<span>&nbsp;</span><bdi>0879931906</bdi>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFFensterComessMarshKatzenberg1983" class="citation journal cs1">Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD (September 1983). "Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion". <i>American Heart Journal</i>. <b>106</b> (3): 501–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0002-8703%2883%2990692-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0002-8703%2883%2990692-0'" tppabs="https://doi.org/10.1016%2F0002-8703%2883%2990692-0" class="external text external">10.1016/0002-8703(83)90692-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6881022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6881022'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6881022" class="external text external">6881022</a>.</cite></span></li><li id="cite_note-ten-5"> <span id="mw-reference-text-cite_note-ten-5" class="mw-reference-text"><cite id="CITEREFKoch-WeserKlein1971" class="citation journal cs1">Koch-Weser J, Klein SW (March 1971). "Procainamide dosage schedules, plasma concentrations, and clinical effects". <i>JAMA</i>. <b>215</b> (9): 1454–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1971.03180220036006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1971.03180220036006'" tppabs="https://doi.org/10.1001%2Fjama.1971.03180220036006" class="external text external">10.1001/jama.1971.03180220036006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5107621  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5107621'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5107621" class="external text external">5107621</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFAntmanSabatine2013" class="citation book cs1">Antman EM, Sabatine MS, eds. (2013). <i>Cardiovascular Therapeutics: A companion to Braunwald's heart disease</i> (4th ed.). Philadelphia, PA: Elsevier/Saunders. p.<span>&nbsp;</span>410. ISBN<span>&nbsp;</span><bdi>978-1-4557-0101-8</bdi>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeSciences-cz/products/AlternativeProductStructure_17319/28411101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeSciences-cz/products/AlternativeProductStructure_17319/28411101'" tppabs="http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeSciences-cz/products/AlternativeProductStructure_17319/28411101" class="external text external">"Procainamide Sepharose 4 Fast Flow"</a>. <i>GE Healthcare Life Sciences</i>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFDe_la_HozDoctorRalstonRush1986" class="citation journal cs1">De la Hoz D, Doctor BP, Ralston JS, Rush RS, Wolfe AD (July 1986). "A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase". <i>Life Sciences</i>. <b>39</b> (3): 195–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0024-3205%2886%2990530-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0024-3205%2886%2990530-8'" tppabs="https://doi.org/10.1016%2F0024-3205%2886%2990530-8" class="external text external">10.1016/0024-3205(86)90530-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3736320  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3736320'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3736320" class="external text external">3736320</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFRalstonMainKilpatrickChasson1983" class="citation journal cs1">Ralston JS, Main AR, Kilpatrick BF, Chasson AL (April 1983). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1154348  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1154348'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1154348" class="external text external">"Use of procainamide gels in the purification of human and horse serum cholinesterases"</a>. <i>The Biochemical Journal</i>. <b>211</b> (1): 243–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1042%2Fbj2110243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1042%2Fbj2110243'" tppabs="https://doi.org/10.1042%2Fbj2110243" class="external text external">10.1042/bj2110243</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1154348  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1154348'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1154348" class="external text external">1154348</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6870822  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6870822'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6870822" class="external text external">6870822</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFSaxenaLuoDoctor2008" class="citation journal cs1">Saxena A, Luo C, Doctor BP (October 2008). "Developing procedures for the large-scale purification of human serum butyrylcholinesterase". <i>Protein Expression and Purification</i>. <b>61</b> (2): 191–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pep.2008.05.021  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pep.2008.05.021'" tppabs="https://doi.org/10.1016%2Fj.pep.2008.05.021" class="external text external">10.1016/j.pep.2008.05.021</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18602477  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18602477'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18602477" class="external text external">18602477</a>.</cite></span></li><li id="cite_note-adverse-11"> <span id="mw-reference-text-cite_note-adverse-11" class="mw-reference-text"><cite id="CITEREFLawsonJick1977" class="citation journal cs1">Lawson DH, Jick H (October 1977). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429167'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429167" class="external text external">"Adverse reactions to procainamide"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>4</b> (5): 507–11. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.1977.tb00777.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.1977.tb00777.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.1977.tb00777.x" class="external text external">10.1111/j.1365-2125.1977.tb00777.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429167'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429167" class="external text external">1429167</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/911600  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/911600'" tppabs="https://pubmed.ncbi.nlm.nih.gov/911600" class="external text external">911600</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFUetrechtZahidRubin1988" class="citation journal cs1">Uetrecht J, Zahid N, Rubin R (January 1988). "Metabolism of procainamide to a hydroxylamine by human neutrophils and mononuclear leukocytes". <i>Chemical Research in Toxicology</i>. <b>1</b> (1): 74–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Ftx00001a013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Ftx00001a013'" tppabs="https://doi.org/10.1021%2Ftx00001a013" class="external text external">10.1021/tx00001a013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2979715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2979715'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2979715" class="external text external">2979715</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFRobertsAdamsDonovan-BrandBudinsky1989" class="citation journal cs1">Roberts SM, Adams LE, Donovan-Brand R, Budinsky R, Skoulis NP, Zimmer H, Hess EV (1989). "Procainamide hydroxylamine lymphocyte toxicity--I. Evidence for participation by hemoglobin". <i>International Journal of Immunopharmacology</i>. <b>11</b> (4): 419–27. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0192-0561%2889%2990089-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0192-0561%2889%2990089-1'" tppabs="https://doi.org/10.1016%2F0192-0561%2889%2990089-1" class="external text external">10.1016/0192-0561(89)90089-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2476407  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2476407'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2476407" class="external text external">2476407</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFGayBrown1974" class="citation journal cs1">Gay RJ, Brown DF (November 1974). "Pacemaker failure due to procainamide toxicity". <i>The American Journal of Cardiology</i>. <b>34</b> (6): 728–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0002-9149%2874%2990164-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0002-9149%2874%2990164-7'" tppabs="https://doi.org/10.1016%2F0002-9149%2874%2990164-7" class="external text external">10.1016/0002-9149(74)90164-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4422040  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4422040'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4422040" class="external text external">4422040</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFRodenReeleHigginsWilkinson1980" class="citation journal cs1">Roden DM, Reele SB, Higgins SB, Wilkinson GR, Smith RF, Oates JA, Woosley RL (September 1980). "Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide". <i>The American Journal of Cardiology</i>. <b>46</b> (3): 463–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0002-9149%2880%2990016-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0002-9149%2880%2990016-8'" tppabs="https://doi.org/10.1016%2F0002-9149%2880%2990016-8" class="external text external">10.1016/0002-9149(80)90016-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6158263  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6158263'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6158263" class="external text external">6158263</a>.</cite></span></li><li id="cite_note-Uetrecht,_J._P._1981-16"> <span id="mw-reference-text-cite_note-Uetrecht,_J._P._1981-16" class="mw-reference-text"><cite id="CITEREFUetrechtFreemanWoosley1981" class="citation journal cs1">Uetrecht JP, Freeman RW, Woosley RL (August 1981). "The implications of procainamide metabolism to its induction of lupus". <i>Arthritis and Rheumatism</i>. <b>24</b> (8): 994–1003. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fart.1780240803  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fart.1780240803'" tppabs="https://doi.org/10.1002%2Fart.1780240803" class="external text external">10.1002/art.1780240803</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6169352  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6169352'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6169352" class="external text external">6169352</a>.</cite></span></li><li id="cite_note-Drug-17"> <span id="mw-reference-text-cite_note-Drug-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.drugbank.ca/drugs/DB01035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugbank.ca/drugs/DB01035'" tppabs="http://www.drugbank.ca/drugs/DB01035" class="external text external">"Procainamide"</a>. <i>www.drugbank.ca</i>. 27 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">28 June</span> 2018</span>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFAdams1995" class="citation book cs1">Adams HR (1995). <i>Drugs Acting on the Cardiovascular System. Veterinary Pharmacology and Therapeutics</i> (7th ed.). pp.<span>&nbsp;</span>451–500.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFPlumb1999" class="citation book cs1">Plumb DC (1999). <i>Veterinary Drug Handbook</i>. White Bear Lake, USA: PharmaVet Publishing.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFEBI_Web_Team" class="citation web cs1">EBI Web Team. <a href="javascript:if(confirm('http://www.ebi.ac.uk/chebi/searchFreeText.do?searchString=51-06-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ebi.ac.uk/chebi/searchFreeText.do?searchString=51-06-9'" tppabs="http://www.ebi.ac.uk/chebi/searchFreeText.do?searchString=51-06-9" class="external text external">"CHEBI:8428 - procainamide"</a>. <i>www.ebi.ac.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">28 June</span> 2018</span>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFDeRuiter2005" class="citation book cs1">DeRuiter J (2005). "Amides and Related Functional Groups". <i>Principles of Drug Action</i>. p.<span>&nbsp;</span>1.</cite></span></li><li id="cite_note-dafda-22"> <span id="mw-reference-text-cite_note-dafda-22" class="mw-reference-text"><cite id="CITEREFUS_Food_and_Drug_Administration" class="citation web cs1">US Food and Drug Administration. <a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm'" tppabs="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm" class="external text external">"Drugs at FDA: FDA Approved Drug Products"</a>. USA: U.S. Food and Drug Administration (FDA)<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-08-13</span></span>.</cite></span></li><li id="cite_note-pmid18610401-23"> <span id="mw-reference-text-cite_note-pmid18610401-23" class="mw-reference-text"><cite id="CITEREFHollman1992" class="citation journal cs1">Hollman A (February 1992). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1024743  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1024743'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1024743" class="external text external">"Procaine and procainamide"</a>. <i>British Heart Journal</i>. <b>67</b> (2): 143. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fhrt.67.2.143  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fhrt.67.2.143'" tppabs="https://doi.org/10.1136%2Fhrt.67.2.143" class="external text external">10.1136/hrt.67.2.143</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1024743  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1024743'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1024743" class="external text external">1024743</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18610401  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18610401'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18610401" class="external text external">18610401</a>.</cite></span></li><li id="cite_note-one-24"> <span id="mw-reference-text-cite_note-one-24" class="mw-reference-text"><cite id="CITEREFWalker2006" class="citation journal cs1">Walker MJ (January 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760742'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760742" class="external text external">"Antiarrhythmic drug research"</a>. <i>British Journal of Pharmacology</i>. 147 Suppl 1: S222-31. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bjp.0706500  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bjp.0706500'" tppabs="https://doi.org/10.1038%2Fsj.bjp.0706500" class="external text external">10.1038/sj.bjp.0706500</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760742'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760742" class="external text external">1760742</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16402108  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16402108'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16402108" class="external text external">16402108</a>.</cite></span></li><li id="cite_note-three-25"> <span id="mw-reference-text-cite_note-three-25" class="mw-reference-text"><cite id="CITEREFMoeAbildskov1965" class="citation book cs1">Moe GK, Abildskov A (1965). "Antiarrhythmic drugs".  In Goodman LS, Gilman A (eds.). <i>Goodman and Gilman's The Pharmacological Basis of Therapeutics</i> (3rd ed.). New York: Macmillan. pp.<span>&nbsp;</span>699–715.</cite></span></li><li id="cite_note-two-26"> <span id="mw-reference-text-cite_note-two-26" class="mw-reference-text"><cite id="CITEREFLüderitz2002" class="citation book cs1">Lüderitz BB, ed. (2002). "Historical development of antiarrhythmic drug therapy". <i>History of Disorders of Cardiac Rhythm</i> (3rd ed.). New York: Wiley-Blackwell. pp.<span>&nbsp;</span>87–114.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFMishinaMarroum2002" class="citation web cs1">Mishina E, Marroum P (2002). <a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/20545s007_Procanbid_biopharmr.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/20545s007_Procanbid_biopharmr.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/20545s007_Procanbid_biopharmr.pdf" class="external text external">"Center for Drug Evaluation and Research Approval Package For: Application Number NDA 20-545/S007"</a> <span class="cs1-format">(PDF)</span>. <i>Clinical Pharmacology and Bioharmaceutics Review</i>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiarrhythmic_agents_(C01B)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiarrhythmic_agents_(C01B)" style="font-size:114%;margin:0 4em">Antiarrhythmic agents (C01B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Channel blockers</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="class_I(Na+_channel_blockers)" scope="row" class="navbox-group" style="width:1%">class I<br>(Na<sup>+</sup> channel blockers)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">class Ia (Phase 0→ and Phase 3→)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ajmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Disopyramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Disopyramide" title="Disopyramide">Disopyramide</a></li>
<li><a href="Dihydroquinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroquinidine" title="Dihydroquinidine">Hydroquinidine</a></li>
<li>Lorajmine</li>
<li>Prajmaline</li>
<li><a href="Procainamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Procainamide" title="Procainamide">Procainamide</a><sup>#</sup></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a><sup>#</sup></li>
<li>Sparteine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">class Ib (Phase 3←)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>IV</i>
<ul><li><a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">Lidocaine</a><sup>#</sup></li></ul></li>
<li><i>enteral</i>
<ul><li><a href="Aprindine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprindine" title="Aprindine">Aprindine</a></li>
<li><a href="Mexiletine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li><a href="Tocainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tocainide" title="Tocainide">Tocainide</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">class Ic (Phase 0→)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Encainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Encainide" title="Encainide">Encainide</a><sup>‡</sup></li>
<li>Ethacizine</li>
<li><a href="Flecainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flecainide" title="Flecainide">Flecainide</a></li>
<li><a href="Indecainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Indecainide" title="Indecainide">Indecainide</a><sup>‡</sup></li>
<li>Lorcainide</li>
<li><a href="Moracizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Moracizine" title="Moracizine">Moracizine</a><sup>‡</sup></li>
<li><a href="Propafenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Propafenone" title="Propafenone">Propafenone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">class III<br>(Phase 3→, K<sup>+</sup> channel blockers)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Bretylium.htm" tppabs="https://ptable.com/wiki/compounds/A/Bretylium" title="Bretylium">Bretylium</a></li>
<li>Bunaftine</li>
<li>Celivarone<sup>†</sup></li>
<li><a href="Dofetilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dofetilide" title="Dofetilide">Dofetilide</a></li>
<li>Dronedarone</li>
<li>E-4031<sup>†</sup></li>
<li><a href="Ibutilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibutilide" title="Ibutilide">Ibutilide</a></li>
<li>Nifekalant</li>
<li><a href="Sotalol.htm" tppabs="https://ptable.com/wiki/compounds/A/Sotalol" title="Sotalol">Sotalol</a></li>
<li>Tedisamil</li>
<li>Vernakalant</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">class IV<br>(Phase 4→, Ca<sup>2+</sup> channel blockers)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Diltiazem.htm" tppabs="https://ptable.com/wiki/compounds/A/Diltiazem" title="Diltiazem">Diltiazem</a></li>
<li><a href="Verapamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Verapamil" title="Verapamil">Verapamil</a><sup>#</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Receptor agonists<br>and antagonists</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">class II<br>(Phase 4→, β blockers)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Nadolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nadolol" title="Nadolol">Nadolol</a></li>
<li><a href="Pindolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pindolol" title="Pindolol">Pindolol</a></li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li><i>cardioselective</i>
<ul><li><a href="Acebutolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Acebutolol" title="Acebutolol">Acebutolol</a></li>
<li><a href="Atenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Atenolol" title="Atenolol">Atenolol</a></li>
<li><a href="Esmolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Esmolol" title="Esmolol">Esmolol</a></li>
<li><a href="Metoprolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoprolol" title="Metoprolol">Metoprolol</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">A<sub>1</sub> agonist</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Adenosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine" title="Adenosine">Adenosine</a></li>
<li>Benzodiazepines</li>
<li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">M<sub>2</sub></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>muscarinic antagonist: <a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a></li>
<li><a href="Disopyramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Disopyramide" title="Disopyramide">Disopyramide</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a><br>muscarinic agonist: <a href="Digoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digoxin" title="Digoxin">Digoxin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">α receptors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Bretylium.htm" tppabs="https://ptable.com/wiki/compounds/A/Bretylium" title="Bretylium">Bretylium</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Verapamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Verapamil" title="Verapamil">Verapamil</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ion transporters</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Na+/_K+-ATPase" scope="row" class="navbox-group" style="width:1%">Na<sup>+</sup>/ K<sup>+</sup>-ATPase</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Digitoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digitoxin" title="Digitoxin">Digitoxin</a></li>
<li><a href="Digoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digoxin" title="Digoxin">Digoxin</a></li>
<li><a href="Ouabain.htm" tppabs="https://ptable.com/wiki/compounds/A/Ouabain" title="Ouabain">Ouabain</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>





<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>